Mainz Biomed and Thermo Fisher Scientific sign collaboration agreement

Development of next-generation colorectal cancer screening product for global markets

14-Nov-2024 - Mainz Biomed N.V. announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. The collaboration agreement will enable Mainz Biomed and ...

Artificial intelligence improves lung cancer diagnosis

New AI-based digital platform enables extremely fast and accurate analysis of tissue sections from lung cancer patients

27-Aug-2024 - A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence. The platform uses new algorithms developed by the team ...

DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier

Precise cancer classification of subtypes that are otherwise difficult or impossible to distinguish

16-Jul-2024 - Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor ...

AI model finds the cancer clues at lightning speed

Say goodbye to hours, even days, of detective work

08-Jul-2024 - Researchers at the University of Gothenburg have developed an AI model that increases the potential for detecting cancer through sugar analyses. The AI model is faster and better at finding abnormalities than the current semi-manual method. Glycans, or structures of sugar molecules in our cells, ...

AI-supported image analysis: metrics determine quality

New online tool helps to select the right algorithm

14-Feb-2024 - How well do the algorithms used in the AI-supported analysis of medical images perform their respective tasks? This depends to a large extent on the metrics used to evaluate their performance. An international consortium led by scientists from the German Cancer Research Center (DKFZ) and the ...

AI-based support system for skin cancer diagnostics explains its decisions

The explanations increased doctors' confidence in the machine's decisions - as well as in their own diagnoses

19-Jan-2024 - Artificial intelligence (AI) can help dermatologists to detect skin cancer. However, many dermatologists distrust the algorithms' decisions, which they cannot comprehend. Scientists at the German Cancer Research Center have now developed an AI-based support system for skin cancer diagnostics that ...

Leukaemia: artificial intelligence provides support in diagnostics

IT specialists and physicians develop new method for recognising genetic aberrations

16-Jan-2024 - Decisions on treatment for patients with acute myeloid leukemia(AML) – a highly aggressive form of leukemia– are based, among other things, on a series of certain genetic features of the disease; but at the time when a diagnosis is made, this information is not available. However, evidence of ...

Enabling early detection of cancer: AI helps

Blood cells reveal tumours in the body: Researchers achieve an advance with the development of a test for early diagnosis of cancer

18-Dec-2023 - The ability to detect a developing tumour at a very early stage and to closely monitor the success or failure of cancer therapy is crucial for a patient’s survival. A breakthrough on both counts has now been achieved by researchers at the Paul Scherrer Institute PSI. Researchers led by G.V. ...

A sugar analysis could reveal different types of cancer

In the future, a little saliva may be enough to detect an incipient cancer

15-Dec-2023 - Researchers at the University of Gothenburg have developed an effective way to interpret the changes in sugar molecules that occur in cancer cells. Glycans are a type of sugar molecule structures that is linked to the proteins in our cells. The structure of the glycan determines the function of ...

Hong Kong firm invests in Jena-based Oncgnostics GmbH

12-Sep-2023 - The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. Since 2022, this test has also been ...